title: [Expression of stem cell markers on fetal and tumoral human liver cells in primary culture].
abstract: Hepatic stem cells can be identified by the expression of putative markers such as CD117 (c-kit), CD90 (Thy-1), CD34, and HLA-DR. We have identified populations expressing these markers in both fetal and tumoral human liver by flow cytometry, using monoclonal antibodies against CD90, CD117, CD34, and HLA-DR. In tumoral liver CD117+/CD90+ cells were found in decreasing number from the neoplastic (2.48 +/- 0.67) and peritumoral region (0.88 +/- 0.12) to the area of para-tumoral (normal) parenchyma (0.13 +/- 0.04). The CD117+/CD34+ cells showed the following distribution: 0.35 +/- 0.05% in the tumoral region, 1.01 +/- 0.23% in the peritumoral region and 0.35 +/- 0.01 in the para-tumoral region. Using the same markers on fetal liver cells we have also identified small populations of CD117+/CD90+ cells (0.28 +/- 0.07%) and CD117+/CD34+ cells (1.13 +/- 0.24%), presumably resident stem cells or hematopoietic stem cells. Immunomagnetic negative separation was then performed on fetal liver cells using monoclonal antibodies against specific markers of hematopoietic lineages such as CD3, 14, 16, 19, 22, and CD56 to eliminate this population. The remaining cells were then incubated with fluorescently labeled monoclonal antibodies against CD90 and CD117 and analyzed using fluorescence microscopy. As expected these markers were expressed on the majority of the selected cells (89.28 +/- 9.56%). Isolation using appropriate markers and initiation of primary cultures is a first step to the therapeutic use of fetal stem cells and for the study of adult liver stem cells involvement in carcinogenesis.
authors.affiliation: Universitatea de Medicină şi Farmacie Carol Davila Bucureşti, Catedra de Medicină Celulară şi Moleculară.
authors.forename: L
authors.initials: L
authors.lastname: Ceafalan
authors.forename: Cristina
authors.initials: C
authors.lastname: Vidulescu
authors.forename: E
authors.initials: E
authors.lastname: Radu
authors.forename: T
authors.initials: T
authors.lastname: Regalia
authors.forename: I
authors.initials: I
authors.lastname: Popescu
authors.forename: M
authors.initials: M
authors.lastname: Pana
authors.forename: L
authors.initials: L
authors.lastname: Serghei
authors.forename: B
authors.initials: B
authors.lastname: Voiculescu
authors.forename: L M
authors.initials: LM
authors.lastname: Popescu
mesh_terms: D000328:Adult; D018952:Antigens, CD34 / Q000032:analysis; D015415:Biomarkers / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D006528:Carcinoma, Hepatocellular / Q000276:immunology*; D005333:Fetus; D005434:Flow Cytometry; D006684:HLA-DR Antigens / Q000032:analysis; D022781:Hepatocytes / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D018189:Immunomagnetic Separation; D008113:Liver Neoplasms / Q000276:immunology*; D008856:Microscopy, Fluorescence; D019009:Proto-Oncogene Proteins c-kit / Q000032:analysis; D033581:Stem Cell Transplantation / Q000379:methods; D013234:Stem Cells; D018800:Thy-1 Antigens / Q000032:analysis
chemical_list: D018952:Antigens, CD34; D015415:Biomarkers; D014408:Biomarkers, Tumor; D006684:HLA-DR Antigens; D018800:Thy-1 Antigens; D019009:Proto-Oncogene Proteins c-kit